MedTrace Logo

Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases

NCT06983366 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2026-04-30

No results posted yet for this study

Summary

This upcoming case-control study aims to confirm the Lung Sliding Index (LSI), a new ultrasound score that measures how well the pleura moves, in various lung diseases. The study will check how well the LSI can tell apart different lung diseases (like pneumothorax, interstitial lung disease, COPD, pneumonia, and pulmonary edema), how it relates to signs of disease severity, and how consistent the results are between different operators who have received the same training. Secondary objectives include assessing patient and operator satisfaction and feasibility using validated Likert scales.

Conditions

Interventions

DIAGNOSTIC_TEST

Lung Ultrasound

All enrolled patient will be subjected to Lung Ultrasound examination LUS

Sponsors & Collaborators

  • Aliae AR Mohamed Hussein [ahussein

    collaborator UNKNOWN

  • Assiut University

    lead OTHER

Principal Investigators

  • Ahmad M. Shaddad, MD · Assiut University

  • Aliae A. Hussien, MD · Assiut University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-30
Primary Completion
2026-07-01
Completion
2026-08-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06983366 on ClinicalTrials.gov